Shandong Pharmaceutical Glass Co Ltd
SSE:600529
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
CN |
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
18.9B CNY | 3.9 | |
CH |
Alcon AG
SIX:ALC
|
40B CHF | 4.7 | ||
JP |
Hoya Corp
TSE:7741
|
6.8T JPY | 9 | ||
DK |
Coloplast A/S
CSE:COLO B
|
188.7B DKK | 7.5 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
20.9B USD | 5.3 | ||
US |
Cooper Companies Inc
NYSE:COO
|
19.3B USD | 5.2 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
12.3T KRW | 286.4 | |
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
58.5B CNY | 14.4 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.4B GBP | 3.2 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.9B USD | 1.5 | ||
US |
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.5B USD | 4 |
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.